AURE FARMA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 3,309,193 | 2,989,540 | 3,694,312 | 6,227,169 | 5,804,381 | 7,846,580 | 9,211,144 | 9,311,182 |
| Profit before tax | 366,148 | 336,461 | 369,430 | 735,696 | 336,726 | 175,135 | 307,691 | 692,549 |
| Net profit | 310,788 | 285,761 | 314,015 | 665,771 | 286,170 | 147,915 | 266,760 | 628,514 |
| Equity | 565,255 | 795,015 | 959,030 | 1,304,802 | 1,191,933 | 1,039,847 | 1,306,607 | 1,785,121 |
| Liabilities | 146,976 | 57,340 | 259,135 | 56,917 | 182,953 | 370,669 | 68,133 | 244,266 |
| Non-current assets | 0 | 45,868 | 39,272 | 91,357 | 174,995 | 189,948 | 226,950 | 259,369 |
| Current assets | 712,231 | 806,487 | 1,178,893 | 1,270,362 | 1,199,891 | 1,220,568 | 1,144,304 | 1,766,219 |
| Total assets | 712,231 | 852,355 | 1,218,165 | 1,361,719 | 1,374,886 | 1,410,516 | 1,371,254 | 2,025,588 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 45,253 | - | - |
| Social insurance contributions | - | - | - | - | - | 61,063 | 62,200 | 62,659 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -13.6% | -9.7% | +23.6% | +68.6% | -6.8% | +35.2% | +17.4% | +1.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 43.6% | 33.5% | 25.8% | 48.9% | 20.8% | 10.5% | 19.5% | 31.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 55.0% | 35.9% | 32.7% | 51.0% | 24.0% | 14.2% | 20.4% | 35.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 9.4% | 9.6% | 8.5% | 10.7% | 4.9% | 1.9% | 2.9% | 6.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 11.1% | 11.3% | 10.0% | 11.8% | 5.8% | 2.2% | 3.3% | 7.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.1 | 0.3 | 0.0 | 0.2 | 0.4 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 496,376 | 403,082 | 461,789 | 778,396 | 725,548 | 980,823 | 1,163,508 | 1,509,913 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
AURE FARMA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-06-08 | 0.01 |
| 2022-10-18 | 2022-10-27 | 0.01 |
AURE FARMA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
AURE FARMA, UAB (company code 303430907) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €9.31M, up 1.1% year on year and 18.7% over two years. Net profit increased to €628.5K, compared with €266.8K in 2024 and €147.9K in 2023, showing a clear improvement in profitability. The profit margin widened from 1.9% in 2023 to 2.9% in 2024 and 6.8% in 2025. Balance sheet strength also improved: total assets rose to €2.03M, equity to €1.79M, and liabilities remained moderate at €244.3K. The equity ratio stood at 88.1% and debt-to-equity at 0.14, indicating a very conservative capital structure. Asset turnover was 4.60x, while revenue per employee reached €1.55M and profit per employee €104.8K, pointing to strong operating productivity.